Varian develops intelligent cancer care

Varian Finland is a significant software company in Finland. Most employees are specialists who use their extensive skills in software development, applied mathe‐ matics, and physics to develop Varian’s radiotherapy software, cancer treatment solutions, and cloud‐based solutions to capture patient‐reported outcomes. Varian Finland currently employs approximately 300 people of more than 20 nationalities from around the world. Varian Finland’s roots are in Dosetek Oy, which was established in 1980, and be‐ came a subsidiary of Varian in 1993. Today, Varian Finland develops the world’s leading radiotherapy treatment planning systems. Varian acquired the Finnish health technology developer Noona Healthcare in 2018, and thus complemented its cancer treatment solutions with a cloud‐based mobile application. In Finland, almost all cancer hospitals use radiation therapy equipment or soft‐ ware developed by Varian.

Harnessing advanced technologies to expand access to care

At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. Varian software connects treatment providers, patients, and data into one eco‐ system that keeps all stakeholders informed and confident. Varian is deeply committed to the ongoing development of innovative treatment offerings for clinicians, for example, offering ablation and embolization services to patients, and to helping advance the field of interventional oncology. With an intelligent cancer care approach, we are harnessing advanced technolo‐ gies like artificial intelligence, machine learning, and data analytics to enhance cancer treatments and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. The fight of every cancer patient is our fight.

“It is great that Varian is deepening co‐operation within Clever Health Network. I believe this provides us new opportunities to utilize Finnish knowledge network and data lakes. And in this way we can participate in promoting the emergence of new innovations in cancer technology. This is also a great opportunity for us to present the opportunities Finland can offer to other Varian business units across the globe – you do not always need to operate only with large U.S. hospital corporations.”
− Kari Toimela, Managing Director of Varian Medical Systems Finland